Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bentley Pharmaceuticals to Report Fourth Quarter and Full-Year 2005 Financial Results on March 8, 2006.


EXETER, N.H. -- Bentley Pharmaceuticals, Inc. (NYSE NYSE

See: New York Stock Exchange
: BNT BNT Bentley Pharmaceuticals, Inc. (stock symbol)
BNT Boston Naming Test (psychology)
BNT Bermuda National Trust
BNT Bulgarian National TV
BNT Broadband Network Termination
BNT Binary File Transfer
), a specialty pharmaceutical and drug delivery company, today announced it will host a conference call to discuss its fourth quarter and full year 2005 financial results on Thursday, March 9, 2006 at 10:00 a.m. Eastern Standard Time. The call will follow the release of these financial results on Wednesday, March 8, 2006, after the closing of the market.

To listen to the conference call, please dial 866-425-6192 (United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  and Canada) or 973-935-2981 (International). The access code for the call is 7097569. Please dial in approximately 10 minutes before the start of the conference call. You can access a live webcast of this conference on the Company's web site at www.bentleypharm.com. The webcast will be archived for 90 days.

A playback Playback could mean:
  • The re-playing of recorded media.
  • Gapless playback, the seamless playback of digital audio formats (i. e. ipods, mp3 players)
  • Playback singer, a practice in Bollywood musicals.
 of the call will be available from approximately 1:00 p.m. Eastern Standard Time on March 9, 2006 through March 16, 2006. You can access the playback at 877-519-4471 (United States and Canada) or 973-341-3080 (International). Please reference reservation number 7097569.

Bentley Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on advanced drug delivery technologies and pharmaceutical products. Bentley's proprietary drug technologies enhance or facilitate the absorption of pharmaceutical compounds across various membranes. Bentley also manufactures a growing portfolio of generic and branded pharmaceuticals in Europe for the treatment of cardiovascular, gastrointestinal gastrointestinal /gas·tro·in·tes·ti·nal/ (-in-tes´ti-n'l) pertaining to or communicating with the stomach and intestine.

gas·tro·in·tes·ti·nal
adj.
Abbr.
, infectious and neurological diseases Noun 1. neurological disease - a disorder of the nervous system
nervous disorder, neurological disorder

disorder, upset - a physical condition in which there is a disturbance of normal functioning; "the doctor prescribed some medicine for the disorder";
 through its subsidiary, Laboratorios Belmac, and markets these pharmaceutical products through its subsidiaries, Laboratorios Belmac, Laboratorios Davur, Laboratorios Rimafar and Bentley Pharmaceuticals Ireland; and manufactures and markets active pharmaceutical ingredients through its subsidiary, Bentley API (Application Programming Interface) A language and message format used by an application program to communicate with the operating system or some other control program such as a database management system (DBMS) or communications protocol. .

Copies of Bentley Pharmaceuticals' press releases and other information may be obtained through Bentley's web site at www.bentleypharm.com.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Mar 1, 2006
Words:285
Previous Article:Clinical Data Launches PGxHEALTH(TM) and COGENICS(TM); PGxHEALTH Engaged in Discovery of Biomarkers and Introducing Therapeutic Diagnostics(TM).
Next Article:Boardwalk Pipeline Partners Announces $575 Million Pipeline Expansion.
Topics:



Related Articles
Bentley Pharmaceuticals Reports Profitable Fourth Quarter and Improved Results for Year Ended December 31, 1999; Announces Redemption of 12%...
Bentley Pharmaceuticals to Host First Quarter 2006 Conference Call and Webcast on Wednesday May 10, 2006.
Bentley Pharmaceuticals Recognized as One of Fortune's 100 Fastest Growing Companies.
Bentley Pharmaceuticals to Host Second Quarter 2006 Conference Call and Webcast on Thursday August 3, 2006.
Bentley Pharmaceuticals to Host Third Quarter 2006 Conference Call and Webcast on Thursday, November 2, 2006.
Bentley Pharmaceuticals Named One of Forbes 200 Best Small Companies.
Bentley Pharmaceuticals Reports Third Quarter 2006 Results.
Bentley Pharmaceuticals' Pricing in Spain Pressured by New Regulation from the Ministry of Health.
Bentley Pharmaceuticals to Announce Fourth Quarter and Full-Year 2006 Financial Results and Conduct a Conference Call on March 1, 2007.
Bentley Pharmaceuticals Reports $0.10 Diluted EPS on Record Revenues of $31.4 Million in the First Quarter of 2007.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles